Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Four-drug Helicobacter pylori eradication regimen with pantoprazole vs esomeprazole
IRCT20251129068149N1Phase 2Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of pantoprazole and esomeprazole in Helicobacter pylori infection, gastritis and functional dyspepsia (FD) (2 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoint: Helicobacter pylori eradication rate. Started Jan 2026; status: completed.
02
Drugs
pantoprazoleesomeprazole
03
Conditions
Helicobacter pylori infectiongastritisfunctional dyspepsia (FD)
Beyond the preview
Go deeper on IRCT20251129068149N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251129068149N1.